Towards Healthcare
Monoclonal Antibodies Market to Rise USD 823.31 Bn by 2034

Monoclonal Antibodies Market 2025 to 2034 Insights, Key Players, AI Innovations and Growth

Projections indicate that, the global monoclonal antibodie market will increase from USD 254.89 billion in 2024 to USD 823.31 billion by 2034, experiencing a CAGR of 12.44% over the next 10 years. The monoclonal antibodies market is expanding due to growing demand for targeted therapies as well as rising bispecific antibody treatment approaches. North America led the market due to the presence of well-developed industries.

  • Insight Code: 6011
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The monoclonal antibodies market is worth USD 286.6 billion in 2025, and by 2034, it is forecasted to hit USD 823.31 billion, registering a CAGR of 12.44% over the decade.

North America is currently leading the monoclonal antibodies market due to the presence of well developed industries.

Some key players include Roche Genentech, AbbVie, Johnson & Johnson, and Merck & Co.

Monoclonal antibodies are used across oncology, autoimmune inflammatory diseases, infectious diseases, ophthalmology, and other areas.

Advancements in genetic engineering are the factor that drives the market.

American Cancer Society, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.